MedTrace Logo

Impact of Misoprostol on Blood Loss In Myomectomy Operations

NCT02061657 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-08-12

No results posted yet for this study

Summary

The aim of this research work is to assess the effect of using single preoperative dose of rectal misoprostol in abdominal myomectomy operations on blood loss, duration of the operation and possible operative complications

Conditions

  • Leiomyoma

Interventions

DRUG

Misoprostol

25 patients undergoing myomectomy operation will receive two tablets of misoprostol (400 mcg) rectally two hours before the operation

DRUG

Placebo( for misoprostol)

Include 25 patients undergoing myomectomy operation will not receive misoprostol before the operation.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Abd El Mgeed I. Abd El Mgeed, Professor · Ain Shams University

  • Mohamed S. Ali, Professor · Ain Shams University

  • Mohamed A. Abdel-Hafeez, Lecturer · Ain Shams University

  • Mina A. Yacoup, Fellow · Ain Shams University

  • Ahmed M. Elnaggar, Lecturer · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-06-30
Completion
2014-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02061657 on ClinicalTrials.gov